-
101
Clinical Practice Guidelines of the Russian Society for the Study of the Liver, the Russian Gastroenterological Association, the National Scientific Society of Infectious Disease S...
Published 2023-06-01“…Over the past 10 years, great progress has been made in the treatment of hepatitis C — direct acting antiviral drugs have appeared. The spectrum of their effectiveness allows to achieve a sustained virological response in more than 90 % of cases, even in groups that were not previously considered even as candidates for therapy or were difficult to treat — patients receiving renal replacement therapy, after liver transplantation (or other organs), at the stage of decompensated liver cirrhosis, HIV co-infected, etc. …”
Get full text
Article -
102
Prediction of influenza A virus-human protein-protein interactions using XGBoost with continuous and discontinuous amino acids information
Published 2025-01-01“…Identifying protein-protein interactions (PPIs) between IAV and human proteins is beneficial for understanding the mechanism of viral infection and designing antiviral drugs. In this article, we developed a sequence-based machine learning method for predicting PPI. …”
Get full text
Article -
103
Is Avian influenza virus still threatening humans? Preventative measures and treatment
Published 2025-01-01“…As part of preparedness for the next pandemic, specific influenza vaccines are developed and available antiviral drugs are being tested for their effectiveness against strains with pandemic potential. …”
Get full text
Article -
104
Systematic review: characteristics of myocarditis followed by fixed drug eruption and dry eye syndrome in patients who have been vaccinated with monkeypox in children and adults
Published 2025-01-01“…The pathophysiology of myocarditis in Monkeypox patients is not yet determined due to rarity of cases.ConclusionMPOX infection presents unique complications like myocarditis, necessitating research for vaccines, antiviral drugs, and infection prevention measures. Early screening for chest pain and investigating MPXV infection's pathogenesis and clinical features are crucial for differential diagnosis during outbreaks. …”
Get full text
Article -
105
APLASTIC SYNDROME IN A PREGNANT WOMAN ON THE BACKGROUND OF COVID-19: A CLINICAL CASE
Published 2024-11-01“…Patient B. was diagnosed with COVID-19 infection with lung damage at 26 weeks of pregnancy, and was treated with glucocorticosteroids, antiviral drugs, and antibiotics. Later, the clinic of pseudomembranous colitis joined, an etiological factor was discovered – Clostridium difficile. …”
Get full text
Article -
106
Single or multiple treatments with lusutrombopag in subjects with thrombocytopenia and chronic liver disease needing an invasive procedure
Published 2023-08-01“…This article reports two different cases concerning respectively an 83-year-old female patient suffering from arterial hypertension, aneurysm of the sub-renal aorta, hepatitis C virus (HCV)-positive liver cirrhosis responsive to treatment with antiviral drugs, and a 2.0 cm diameter hepatocellular carcinoma (HCC) nodule localized in the hepatic segment III and a 53-year-old female patient with HCV-positive liver cirrhosis complicated by portal hypertension with splenomegaly, thrombocytopenia, and F3 esophageal varices at high risk of bleeding. …”
Get full text
Article -
107
Target-specific peptides for BK virus agnoprotein identified through phage display screening: advancing antiviral therapeutics
Published 2025-01-01“…Despite these challenges, specific antiviral drugs targeting BK virus remain elusive. Agnoprotein, a small, positively charged protein encoded by the BK virus late gene, functions in the assembly, maturation, and release of the virus. …”
Get full text
Article -
108
A cell-based Papain-like Protease (PLpro) activity assay for rapid detection of active SARS-CoV-2 infections and antivirals.
Published 2024-01-01“…Additionally, we show feasibility of the platform as a new homogeneous phenotypic assay for rapid screening of SARS-CoV-2 antiviral drugs and neutralizing antibodies.…”
Get full text
Article -
109
Global progress, challenges and strategies in eliminating public threat of viral hepatitis
Published 2025-02-01“…The objective of this article was to explore the urgent issues that need to be addressed in global viral hepatitis with the increasing availability of vaccines and antiviral drugs. Main text The updated World Health Organization guidelines for the prevention, diagnosis, care and treatment for people with chronic hepatitis B infection (2024 edition) and Chinese guidelines for the prevention and treatment of chronic hepatitis B (version 2022) simplify clinical algorithms for the diagnosis, treatment, and monitoring of hepatitis B, expand treatment eligibility criteria, and provide alternative treatment options, which will cover a higher proportion of all hepatitis B surface antigen positive populations. …”
Get full text
Article -
110
CoviWall, a whole-virion-inactivated B.1.617.2 vaccine candidate, induces potent humoral and Th1 cell response in mice and protects against B.1.617.2 strain challenge in Syrian ham...
Published 2025-01-01“…Rapid development of coronavirus disease 2019 (COVID-19) vaccines and antiviral drugs have significantly reduced morbidity and mortality worldwide. …”
Get full text
Article -
111
Discovery of orally bioavailable SARS-CoV-2 papain-like protease inhibitor as a potential treatment for COVID-19
Published 2024-11-01“…Currently, all FDA-approved antiviral drugs against SARS-CoV-2 are RdRp or 3CLpro inhibitors. …”
Get full text
Article -
112
Discovering broad-spectrum inhibitors for SARS-CoV-2 variants: a cheminformatics and biophysical approach targeting the main protease
Published 2025-02-01“…The COVID-19 pandemic caused by SARS-CoV-2 still lacks effective antiviral drugs. Therefore, a thorough receptor-based virtual screening study was conducted to screen different natural and synthetic drug libraries, such as the Asinex Antiviral, Seaweed Metabolite Database, Medicinal Fungi Secondary Metabolite and Therapeutics Library, and Comprehensive Marine Natural Products Database comprising 6,827, 1,191, 1,830, and 45,000 compounds, respectively, against the main protease enzyme of SARS-CoV-2. …”
Get full text
Article -
113
Co-dynamics of hepatitis B and C viruses under the influence of CTL immunity
Published 2025-04-01“…The results indicate that both the length of the delay period and the efficacy of antiviral drugs independently contribute to reducing HBV and HCV levels, thereby improving liver health. …”
Get full text
Article -
114
Therapeutic potential of the neutralizing monoclonal antibody 45G3 against encephalomyocarditis virus
Published 2025-01-01“…These findings position 45G3 as a promising candidate for EMCV management and provide a strong foundation for the future development of antiviral drugs targeting this widespread virus.…”
Get full text
Article -
115
Impact of Oseltamivir and Diabetes Development
Published 2025-01-01“…<b>Background/Objectives</b>: Influenza is a major global health challenge, causing thousands of deaths annually. Antiviral drugs, particularly oseltamivir, a neuraminidase inhibitor, have become essential therapeutic options due to their oral bioavailability and efficacy. …”
Get full text
Article -
116
Association between medication adherence and disease outcomes in patients with hepatitis B-related cirrhosis: a population-based case–control study
Published 2022-06-01“…Medication possession ratio (MPR) is used as a measure of treatment adherence for oral antiviral drugs, and conditional logistic regression models are used to estimate the odds of decompensation and mortality after accounting for MPR and other covariates.Results Between decompensated and compensated patients, longer term treatment adherence is seen higher in the compensated group versus the decompensated group: 1-year MPR (0.65±0.43 vs 0.57±0.53) and 6-month MPR (0.79±0.52 vs 0.76±0.79). …”
Get full text
Article -
117
Peripheral lncRNA NEAT-1, miR374b-5p, and IL6 panel to guide in COVID-19 patients' diagnosis and prognosis.
Published 2024-01-01“…<h4>Background</h4>The SARS-CoV-2 virus's frequent mutations have made disease control with vaccines and antiviral drugs difficult; as a result, there is a need for more effective coronavirus drugs. …”
Get full text
Article -
118
Drug-induced autoimmune-like hepatitis: A disproportionality analysis based on the FAERS database.
Published 2025-01-01“…Disproportionality analysis identified 50 drugs with strong associations to DI-ALH, with biologics, statins, antibiotics, and antiviral drugs representing the most common categories. …”
Get full text
Article -
119
Single-cell transcriptome-wide Mendelian randomization and colocalization reveals immune-mediated regulatory mechanisms and drug targets for COVID-19Research in context
Published 2025-03-01“…Limited effective immune-mediated antiviral drugs have been launched. Methods: We conducted a Mendelian randomization (MR) and colocalization analysis using 26,597 single-cell expression quantitative trait loci (sc-eQTL) to proxy effects of expressions of 16,597 genes in 14 peripheral blood immune cells and tested them against four COVID-19 outcomes from COVID-19 Genetic Housing Initiative GWAS meta-analysis Round 7. …”
Get full text
Article -
120
Thyroid function during COVID-19 and post-COVID complications in adults: a systematic review
Published 2025-02-01“…Medications administered during the acute illness phase, such as corticosteroids and antiviral drugs, can also impact thyroid hormone actions. …”
Get full text
Article